Altimmune, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Altimmune, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Altimmune, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.08M, a 13.6% increase year-over-year.
  • Altimmune, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $13.5M, a 11.7% increase year-over-year.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 31.3% increase from 2022.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.1M, a 46.8% increase from 2021.
  • Altimmune, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.52M, a 114% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.6M +$2.54M +31.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $8.1M +$2.58M +46.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $5.52M +$2.94M +114% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $2.58M +$1.31M +104% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $1.26M +$491K +63.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $773K -$670K -46.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $1.44M +$478K +49.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $965K +$352K +57.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $613K -$1.04M -63% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-14
2014 $1.66M +$293K +21.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $1.36M -$531K -28.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 $1.89M -$672K -26.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $2.57M +$52.8K +2.1% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-11
2010 $2.51M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.